Immunosuppressive drugs for the treatment of atopic dermatitis did not reduce protection conferred by messenger RNA COVID-19 vaccination, according to a study.
“The effectiveness of messenger RNA coronavirus disease 2019 (COVID-19) vaccines in patients with atopic dermatitis (AD) is yet to be delineated,” Khalaf Kridin, MD, of the unit of dermatology and skin research laboratory at Baruch Padeh Poria Medical Center in Tiberias, Israel, and colleagues wrote.
“It remains largely unknown how AD-related immunosuppressive medications affect the development of vaccine-induced immunity,”